<VariationArchive VariationID="536579" VariationName="NM_001110792.2(MECP2):c.1173del (p.Val392fs)" VariationType="Deletion" Accession="VCV000536579" Version="9" RecordType="classified" NumberOfSubmissions="3" NumberOfSubmitters="2" DateLastUpdated="2024-02-20" DateCreated="2018-05-28" MostRecentSubmission="2024-02-14">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="534722" VariationID="536579">
      <GeneList>
        <Gene Symbol="MECP2" FullName="methyl-CpG binding protein 2" GeneID="4204" HGNC_ID="HGNC:6990" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>Xq28</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="154021573" stop="154097717" display_start="154021573" display_stop="154097717" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="153287263" stop="153363187" display_start="153287263" display_stop="153363187" Strand="-" />
          </Location>
          <OMIM>300005</OMIM>
          <Haploinsufficiency last_evaluated="2021-02-22" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=MECP2">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2021-02-22" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=MECP2">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_001110792.2(MECP2):c.1173del (p.Val392fs)</Name>
      <CanonicalSPDI>NC_000023.11:154030690:GGGGG:GGGG</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>Xq28</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="154030691" stop="154030691" display_start="154030691" display_stop="154030691" variantLength="1" positionVCF="154030690" referenceAlleleVCF="CG" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="153296142" stop="153296142" display_start="153296142" display_stop="153296142" variantLength="1" positionVCF="153296141" referenceAlleleVCF="CG" alternateAlleleVCF="C" />
      </Location>
      <ProteinChange>V392fs</ProteinChange>
      <ProteinChange>V380fs</ProteinChange>
      <ProteinChange>V287fs</ProteinChange>
      <ProteinChange>V157fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001369394.2" sequenceAccession="NM_001369394" sequenceVersion="2" change="c.858del">
            <Expression>NM_001369394.2:c.858del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001356323.1" sequenceAccession="NP_001356323" sequenceVersion="1" change="p.Val287fs">
            <Expression>NP_001356323.1:p.Val287fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001386137.1" sequenceAccession="NM_001386137" sequenceVersion="1" change="c.468del">
            <Expression>NM_001386137.1:c.468del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001373066.1" sequenceAccession="NP_001373066" sequenceVersion="1" change="p.Val157fs">
            <Expression>NP_001373066.1:p.Val157fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_004992.4" sequenceAccession="NM_004992" sequenceVersion="4" change="c.1137del" MANEPlusClinical="true">
            <Expression>NM_004992.4:c.1137del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_004983.1" sequenceAccession="NP_004983" sequenceVersion="1" change="p.Val380fs">
            <Expression>NP_004983.1:p.Val380fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001386138.1" sequenceAccession="NM_001386138" sequenceVersion="1" change="c.468del">
            <Expression>NM_001386138.1:c.468del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001373067.1" sequenceAccession="NP_001373067" sequenceVersion="1" change="p.Val157fs">
            <Expression>NP_001373067.1:p.Val157fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001386139.1" sequenceAccession="NM_001386139" sequenceVersion="1" change="c.468del">
            <Expression>NM_001386139.1:c.468del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001373068.1" sequenceAccession="NP_001373068" sequenceVersion="1" change="p.Val157fs">
            <Expression>NP_001373068.1:p.Val157fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.10" sequenceAccession="NC_000023" sequenceVersion="10" change="g.153296146del" Assembly="GRCh37">
            <Expression>NC_000023.10:g.153296146del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.11" sequenceAccession="NC_000023" sequenceVersion="11" change="g.154030695del" Assembly="GRCh38">
            <Expression>NC_000023.11:g.154030695del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007107.3" sequenceAccession="NG_007107" sequenceVersion="3" change="g.111413del">
            <Expression>NG_007107.3:g.111413del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001110792.2" sequenceAccession="NM_001110792" sequenceVersion="2" change="c.1173del" MANESelect="true">
            <Expression>NM_001110792.2:c.1173del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001104262.1" sequenceAccession="NP_001104262" sequenceVersion="1" change="p.Val392fs">
            <Expression>NP_001104262.1:p.Val392fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001316337.2" sequenceAccession="NM_001316337" sequenceVersion="2" change="c.858del">
            <Expression>NM_001316337.2:c.858del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001303266.1" sequenceAccession="NP_001303266" sequenceVersion="1" change="p.Val287fs">
            <Expression>NP_001303266.1:p.Val287fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001369391.2" sequenceAccession="NM_001369391" sequenceVersion="2" change="c.858del">
            <Expression>NM_001369391.2:c.858del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001356320.1" sequenceAccession="NP_001356320" sequenceVersion="1" change="p.Val287fs">
            <Expression>NP_001356320.1:p.Val287fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001369392.2" sequenceAccession="NM_001369392" sequenceVersion="2" change="c.858del">
            <Expression>NM_001369392.2:c.858del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001356321.1" sequenceAccession="NP_001356321" sequenceVersion="1" change="p.Val287fs">
            <Expression>NP_001356321.1:p.Val287fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001369393.2" sequenceAccession="NM_001369393" sequenceVersion="2" change="c.858del">
            <Expression>NM_001369393.2:c.858del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001356322.1" sequenceAccession="NP_001356322" sequenceVersion="1" change="p.Val287fs">
            <Expression>NP_001356322.1:p.Val287fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_004992.3" sequenceAccession="NM_004992" sequenceVersion="3" change="c.1137delC">
            <Expression>NM_004992.3:c.1137delC</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_764" sequenceAccession="LRG_764">
            <Expression>LRG_764:g.111413del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_764t1" sequenceAccession="LRG_764t1">
            <Expression>LRG_764t1:c.1173del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_764p1" sequenceAccession="LRG_764p1" change="p.Val392fs">
            <Expression>LRG_764p1:p.Val392fs</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_764t2" sequenceAccession="LRG_764t2">
            <Expression>LRG_764t2:c.1137del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_764p2" sequenceAccession="LRG_764p2" change="p.Val380fs">
            <Expression>LRG_764p2:p.Val380fs</Expression>
          </ProteinExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA658799893" DB="ClinGen" />
        <XRef Type="rs" ID="1557135793" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001110792.2(MECP2):c.1173del (p.Val392fs) AND Severe neonatal-onset encephalopathy with microcephaly" Accession="RCV000645108" Version="7">
        <ClassifiedConditionList TraitSetID="6528">
          <ClassifiedCondition DB="MedGen" ID="C1968556">Severe neonatal-onset encephalopathy with microcephaly</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2017-10-30" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001110792.2(MECP2):c.1173del (p.Val392fs) AND X-linked intellectual disability-psychosis-macroorchidism syndrome" Accession="RCV001252979" Version="2">
        <ClassifiedConditionList TraitSetID="3217">
          <ClassifiedCondition DB="MedGen" ID="C0796222">X-linked intellectual disability-psychosis-macroorchidism syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2019-04-15" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001110792.2(MECP2):c.1173del (p.Val392fs) AND Rett syndrome" Accession="RCV003322610" Version="1">
        <ClassifiedConditionList TraitSetID="3215">
          <ClassifiedCondition DB="MedGen" ID="C0035372">Rett syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-07-25" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-07-25" NumberOfSubmissions="3" NumberOfSubmitters="2" DateCreated="2018-05-28" MostRecentSubmission="2024-02-14">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">14974082</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">16473305</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">19914908</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">21878110</ID>
        </Citation>
        <DescriptionHistory Dated="2022-08-22">
          <Description>Likely pathogenic</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2022-08-07">
          <Description>Pathogenic/Likely pathogenic</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2020-08-15">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="3215" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3622" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Autism, dementia, ataxia, and loss of purposeful hand use</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Rett's disorder</ElementValue>
                <XRef ID="Rett+syndrome/6294" DB="Genetic Alliance" />
                <XRef ID="68618008" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Rett syndrome</ElementValue>
                <XRef ID="MONDO:0010726" DB="MONDO" />
                <XRef ID="778" DB="Orphanet" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">RTS</ElementValue>
                <XRef Type="MIM" ID="312750" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">RTT</ElementValue>
                <XRef Type="MIM" ID="312750" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">The spectrum of MECP2-related phenotypes in females ranges from classic Rett syndrome to variant Rett syndrome with a broader clinical phenotype (either milder or more severe than classic Rett syndrome) to mild learning disabilities; the spectrum in males ranges from severe neonatal encephalopathy to pyramidal signs, parkinsonism, and macroorchidism (PPM-X) syndrome to severe syndromic/nonsyndromic intellectual disability. Females: Classic Rett syndrome, a progressive neurodevelopmental disorder primarily affecting girls, is characterized by apparently normal psychomotor development during the first six to 18 months of life, followed by a short period of developmental stagnation, then rapid regression in language and motor skills, followed by long-term stability. During the phase of rapid regression, repetitive, stereotypic hand movements replace purposeful hand use. Additional findings include fits of screaming and inconsolable crying, autistic features, panic-like attacks, bruxism, episodic apnea and/or hyperpnea, gait ataxia and apraxia, tremors, seizures, and acquired microcephaly. Males: Severe neonatal-onset encephalopathy, the most common phenotype in affected males, is characterized by a relentless clinical course that follows a metabolic-degenerative type of pattern, abnormal tone, involuntary movements, severe seizures, and breathing abnormalities. Death often occurs before age two years.</Attribute>
                <XRef ID="NBK1497" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">MECP2-Related Disorders</Attribute>
                <XRef ID="NBK1497" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="5696" />
                <XRef ID="5696" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301670</ID>
                <ID Source="BookShelf">NBK1497</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2008">
                <ID Source="pmc">3111012</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2013">
                <ID Source="PubMed">23519317</ID>
              </Citation>
              <XRef ID="3095" DB="Orphanet" />
              <XRef ID="778" DB="Orphanet" />
              <XRef ID="C0035372" DB="MedGen" />
              <XRef ID="MONDO:0010726" DB="MONDO" />
              <XRef Type="MIM" ID="312750" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="3217" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="2902" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">X-linked intellectual disability-psychosis-macroorchidism syndrome</ElementValue>
                <XRef ID="MONDO:0010235" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">PPM-X syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC 13</ElementValue>
                <XRef Type="MIM" ID="300055" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300005.0009" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300005.0017" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300005.0022" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300005.0033" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300005.0015" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300005.0035" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">MRXS13</ElementValue>
                <XRef Type="MIM" ID="300055" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">The spectrum of MECP2-related phenotypes in females ranges from classic Rett syndrome to variant Rett syndrome with a broader clinical phenotype (either milder or more severe than classic Rett syndrome) to mild learning disabilities; the spectrum in males ranges from severe neonatal encephalopathy to pyramidal signs, parkinsonism, and macroorchidism (PPM-X) syndrome to severe syndromic/nonsyndromic intellectual disability. Females: Classic Rett syndrome, a progressive neurodevelopmental disorder primarily affecting girls, is characterized by apparently normal psychomotor development during the first six to 18 months of life, followed by a short period of developmental stagnation, then rapid regression in language and motor skills, followed by long-term stability. During the phase of rapid regression, repetitive, stereotypic hand movements replace purposeful hand use. Additional findings include fits of screaming and inconsolable crying, autistic features, panic-like attacks, bruxism, episodic apnea and/or hyperpnea, gait ataxia and apraxia, tremors, seizures, and acquired microcephaly. Males: Severe neonatal-onset encephalopathy, the most common phenotype in affected males, is characterized by a relentless clinical course that follows a metabolic-degenerative type of pattern, abnormal tone, involuntary movements, severe seizures, and breathing abnormalities. Death often occurs before age two years.</Attribute>
                <XRef ID="NBK1497" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="3506" />
                <XRef ID="3506" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301670</ID>
                <ID Source="BookShelf">NBK1497</ID>
              </Citation>
              <XRef ID="3077" DB="Orphanet" />
              <XRef ID="C0796222" DB="MedGen" />
              <XRef ID="MONDO:0010235" DB="MONDO" />
              <XRef Type="MIM" ID="300055" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="6528" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1150" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Encephalopathy, neonatal severe</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Encephalopathy, neonatal severe, due to MECP2 mutations</ElementValue>
                <XRef ID="Encephalopathy%2C+neonatal+severe%2C+due+to+MECP2+mutations/8310" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Severe neonatal-onset encephalopathy with microcephaly</ElementValue>
                <XRef ID="MONDO:0010397" DB="MONDO" />
                <XRef ID="209370" DB="Orphanet" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The spectrum of MECP2-related phenotypes in females ranges from classic Rett syndrome to variant Rett syndrome with a broader clinical phenotype (either milder or more severe than classic Rett syndrome) to mild learning disabilities; the spectrum in males ranges from severe neonatal encephalopathy to pyramidal signs, parkinsonism, and macroorchidism (PPM-X) syndrome to severe syndromic/nonsyndromic intellectual disability. Females: Classic Rett syndrome, a progressive neurodevelopmental disorder primarily affecting girls, is characterized by apparently normal psychomotor development during the first six to 18 months of life, followed by a short period of developmental stagnation, then rapid regression in language and motor skills, followed by long-term stability. During the phase of rapid regression, repetitive, stereotypic hand movements replace purposeful hand use. Additional findings include fits of screaming and inconsolable crying, autistic features, panic-like attacks, bruxism, episodic apnea and/or hyperpnea, gait ataxia and apraxia, tremors, seizures, and acquired microcephaly. Males: Severe neonatal-onset encephalopathy, the most common phenotype in affected males, is characterized by a relentless clinical course that follows a metabolic-degenerative type of pattern, abnormal tone, involuntary movements, severe seizures, and breathing abnormalities. Death often occurs before age two years.</Attribute>
                <XRef ID="NBK1497" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">MECP2-Related Disorders</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">MECP2-Related Severe Neonatal Encephalopathy</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="Genetics Home Reference (GHR) links">MECP2-related severe neonatal encephalopathy</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="17103" />
                <XRef ID="17103" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301670</ID>
                <ID Source="BookShelf">NBK1497</ID>
              </Citation>
              <XRef ID="209370" DB="Orphanet" />
              <XRef ID="C1968556" DB="MedGen" />
              <XRef ID="MONDO:0010397" DB="MONDO" />
              <XRef Type="MIM" ID="300673" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="2819632" SubmissionDate="2020-04-20" DateLastUpdated="2020-08-16" DateCreated="2020-08-16">
        <ClinVarSubmissionID localKey="CV_396|OMIM:300055" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001428466" DateUpdated="2020-08-16" DateCreated="2020-08-16" Type="SCV" Version="1" SubmitterName="Institute of Human Genetics, University of Leipzig Medical Center" OrgID="506086" OrganizationCategory="clinic" OrgAbbreviation="UKL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-04-15">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Comment>This variant was identified as hemizygous</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="MECP2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_004992.3:c.1137del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="300055" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB7303396</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7535810" SubmissionDate="2023-08-16" DateLastUpdated="2023-08-26" DateCreated="2023-08-26">
        <ClinVarSubmissionID localKey="4091245_NM_001110792.2:c.1173del|OMIM:312750" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004027711" DateUpdated="2023-08-26" DateCreated="2023-08-26" Type="SCV" Version="1" SubmitterName="Institute of Human Genetics, University of Leipzig Medical Center" OrgID="506086" OrganizationCategory="clinic" OrgAbbreviation="UKL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-07-25">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>Criteria applied: PVS1,PS4_MOD,PM2_SUP</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">X-linked dominant inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <Gender>female</Gender>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
            <TraitSet Type="Finding">
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0011344" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0200134" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0002197" />
              </Trait>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="MECP2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001110792.2:c.1173del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="312750" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13762194</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1476600" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2018-05-28">
        <ClinVarSubmissionID localKey="2996443|MedGen:C1968556" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000766850" DateUpdated="2024-02-14" DateCreated="2018-05-28" Type="SCV" Version="4" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-10-30">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">19914908</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">16473305</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">21878110</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">14974082</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. Many different deletions variants in this region of the MECP2 gene have been reported in affected individuals (PMID: 19914908, 16473305, Invitae) and therefore has been defined as a "deletion prone region" (PMID: 21878110, 14974082). This variant has not been reported in the literature in individuals with MECP2-related disease. This variant is not present in population databases (ExAC no frequency). This sequence change results in a premature translational stop signal in the MECP2 gene (p.Val380Cysfs*29). While this is not anticipated to result in nonsense mediated decay, it is expected to delete the last 107 amino acids of the MECP2 protein.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="MECP2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000023.10:g.153296142del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1968556" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12507860</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
          <SubmissionName>SUB3864685</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7535810" TraitType="Finding" MappingType="XRef" MappingValue="HP:0002197" MappingRef="HP">
        <MedGen CUI="C0234533" Name="Generalized-onset seizure" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7535810" TraitType="Finding" MappingType="XRef" MappingValue="HP:0200134" MappingRef="HP">
        <MedGen CUI="C0543888" Name="Epileptic encephalopathy" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7535810" TraitType="Disease" MappingType="XRef" MappingValue="312750" MappingRef="OMIM">
        <MedGen CUI="C0035372" Name="Rett syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1476600" TraitType="Disease" MappingType="XRef" MappingValue="C1968556" MappingRef="MedGen">
        <MedGen CUI="C1968556" Name="Severe neonatal-onset encephalopathy with microcephaly" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7535810" TraitType="Finding" MappingType="XRef" MappingValue="HP:0011344" MappingRef="HP">
        <MedGen CUI="C1837397" Name="Severe global developmental delay" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2819632" TraitType="Disease" MappingType="XRef" MappingValue="300055" MappingRef="OMIM">
        <MedGen CUI="C0796222" Name="X-linked intellectual disability-psychosis-macroorchidism syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

